Novel O-palmitoylscleroglucan-coated liposomes as drug carriers: development, characterization and interaction with leuprolide.
Polysaccharide-coated liposomes have been studied for their potential use for peptide drug delivery by the oral route because they are able to minimize the disruptive influences on peptide drugs of gastrointestinal fluids. The aim of this work was to synthesize and characterize a modified polysaccharide, O-palmitoylscleroglucan (PSCG), and to coat unilamellar liposomes for oral delivery of peptide drugs. To better evaluate the coating efficiency of PSCG, also scleroglucan (SCG)-coated liposomes were prepared. We studied the surface modification of liposomes and the SCG- and PSCG-coated liposomes were characterized in terms of size, shape, zeta potential, influence of polymer coating on bilayer fluidity, stability in serum, in simulated gastric and intestinal fluids and against sodium cholate and pancreatin. Leuprolide, a synthetic superpotent agonist of luteinizing hormone releasing hormone (LHRH) receptor, was chosen as a model peptide drug. After polymer coating the vesicle dimensions increased and the zeta potential shifted to less negative values. These results indicate that both SCG- and PSCG-coated liposomes surface and DSC results showed that PSCG was anchored on the liposomal surface. The stability of coated-liposomes in SGF, sodium cholate solution and pancreatin solution was increased. From this preliminary in vitro studies, it seems that PSCG-coated liposomes could be considered as a potential carrier for oral administration.
Carafa
M
M
Dept. Scienze del Farmaco, University G. D'Annunzio, Via dei Vestini, 66100 Chieti, Italy. mcarafa@unich.it
Marianecci
C
C
Annibaldi
V
V
Di Stefano
A
A
Sozio
P
P
Santucci
E
E
D000818:Animals; D002417:Cattle; D002626:Chemistry, Pharmaceutical; D016503:Drug Delivery Systems / Q000379:methods; D004355:Drug Stability; D005300:Fertility Agents, Female / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics; D005750:Gastric Juice / Q000737:chemistry / Q000378:metabolism; D005936:Glucans / Q000097:blood / Q000138:chemical synthesis / Q000737:chemistry*; D007419:Intestinal Secretions / Q000737:chemistry / Q000378:metabolism; D016729:Leuprolide / Q000008:administration & dosage / Q000737:chemistry* / Q000493:pharmacokinetics; D008051:Lipid Bilayers / Q000737:chemistry; D008081:Liposomes / Q000097:blood / Q000138:chemical synthesis / Q000737:chemistry*; D009682:Magnetic Resonance Spectroscopy / Q000379:methods; D036103:Nanotechnology / Q000379:methods; D010194:Pancreatin / Q000737:chemistry / Q000378:metabolism; D010316:Particle Size; D020358:Sodium Cholate / Q000737:chemistry / Q000378:metabolism; D013055:Spectrophotometry, Infrared / Q000379:methods; D055672:Static Electricity
D005300:Fertility Agents, Female; D005936:Glucans; D008051:Lipid Bilayers; D008081:Liposomes; C517482:O-palmitoylscleroglucan; C045938:scleroglucan; D010194:Pancreatin; D016729:Leuprolide; D020358:Sodium Cholate